Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1997-12-2
|
pubmed:abstractText |
Galectin-1 is a member of beta-galactoside-binding lectins expressed in a variety of mammalian tissues. We report here that galectin-1 mRNA is abundantly expressed in the mouse reproductive organs such as the uterus and ovary. Uterine expression of galectin-1 mRNA is specifically regulated in the embryonic implantation process. Its expression increased at a high level on the fifth day post coitum (dpc 5) when embryos hatched into the endometrial epithelial cells. In the absence of embryos, however, galectin-1 expression in the mouse uterus decreased on dpc 5. In the delayed implantation mice, galectin-1 mRNA levels was augmented by the termination of the delay of implantation. Ovarian steroids progesterone and estrogen differentially regulated galectin-1 mRNA level in uterine tissues. Treatment with RU486, a progesterone receptor antagonist, blocked progesterone-induced galectin-1 mRNA level in uterine tissues of ovariectomized mouse. ICI182780, a pure estrogen receptor antagonist, clearly blocked the estrogen effect. Taken together, galectin-1 gene expression in the uterine tissues was regulated by ovarian steroids and this regulation correlated with the implantation process.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Estradiol,
http://linkedlifedata.com/resource/pubmed/chemical/Estradiol Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Galectin 1,
http://linkedlifedata.com/resource/pubmed/chemical/Hemagglutinins,
http://linkedlifedata.com/resource/pubmed/chemical/Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1040-452X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
261-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9291476-Animals,
pubmed-meshheading:9291476-Blastocyst,
pubmed-meshheading:9291476-Embryo Implantation,
pubmed-meshheading:9291476-Embryo Implantation, Delayed,
pubmed-meshheading:9291476-Estradiol,
pubmed-meshheading:9291476-Estradiol Antagonists,
pubmed-meshheading:9291476-Female,
pubmed-meshheading:9291476-Galectin 1,
pubmed-meshheading:9291476-Gene Expression Regulation, Developmental,
pubmed-meshheading:9291476-Hemagglutinins,
pubmed-meshheading:9291476-Mice,
pubmed-meshheading:9291476-Progesterone,
pubmed-meshheading:9291476-RNA, Messenger,
pubmed-meshheading:9291476-Uterus
|
pubmed:year |
1997
|
pubmed:articleTitle |
Expression of galectin-1 mRNA in the mouse uterus is under the control of ovarian steroids during blastocyst implantation.
|
pubmed:affiliation |
Department of Molecular Biology, College of Natural Sciences, Seoul National University, Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|